Report cover image

Biopharmaceuticals Market

Publisher Coherent Market Insights
Published Aug 12, 2025
Length 150 Pages
SKU # CMI20399681

Description

A biopharmaceutical is a therapeutic drug manufactured in, extracted from, or semi-synthesized from biological sources. Biopharmaceuticals include a wide range of products such as vaccines, therapeutic proteins, blood and blood components, tissues, etc. Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science.

Market Dynamics

Increasing burden of chronic, infectious, and neurological diseases, growing geriatric population, increase in research and development (R&D), and outbreak of COVID-19 (pandemic) are major factors expected to augment the growth of the global biopharmaceuticals market.

For instance, in October 2022, Phanes Therapeutics, Inc. received clearance from the US Food and Drug Administration (FDA) to commence Phase I studies with PT217, its anti-Delta-like ligand 3 (DLL3)/anti-Cluster of differentiation 47 (CD47) bispecific antibody being developed for patients with small cell lung cancer (SCLC) and other neuroendocrine cancer. PT217 recently been granted an orphan drug designation by the FDA for the treatment of SCLC.

Key features of the study
  • This report provides in-depth analysis of the global biopharmaceuticals market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global biopharmaceuticals market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Amgen Inc., GlaxoSmithKline PLC, Pfizer Inc., Novo Nordisk AS, Novartis AG, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb Company, Abbvie Inc., and F. Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global biopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceuticals market.
Market Segmentation
  • Global Biopharmaceuticals Market, By Product Type
  • Monoclonal Antibodies
  • Recombinant Growth Factors
  • Purified Proteins
  • Recombinant Proteins
  • Recombinant Hormones
  • Vaccines
  • Recombinant Enzymes
  • Cell and Gene Therapies
  • Synthetic Immunomodulators
  • Other Product Types
  • Global Biopharmaceuticals Market, By Therapeutic Application
  • Oncology
  • Inflammatory and Infectious Diseases
  • Autoimmune Disorders
  • Metabolic Disorders
  • Hormonal Disorders
  • Cardiovascular Diseases
  • Neurological Diseases
  • Other Diseases
  • Global Biopharmaceuticals Market, By Geography
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Company Profiles
  • Amgen Inc.
  • Abbvie Inc.
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Novo Nordisk AS
  • Novartis AG
  • Johnson & Johnson
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • F.Hoffmann-La Roche Ltd.

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Therapeutic Application
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rise in patient pool and growing geriatric population
High-end manufacturing requirements
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Biopharmaceuticals Market, By Product Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021– 2032
Segment Trends
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Growth Factors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Purified Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Proteins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Hormones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Enzymes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell and Gene Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Synthetic Immunomodulators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Product Types
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Biopharmaceuticals Market, By Therapeutic Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021– 2032
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inflammatory and Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hormonal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Biopharmaceuticals Market, By Geography, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021– 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
China
India
Japan
Australia
South Kores
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020-2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
GCC Countries
Israel
Rest of Middle East
South Africa
North Africa
Central Africa
7. Competitive Landscape
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbvie Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novo Nordisk AS
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
8. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us